Related Experiment Videos
Chronic inflammatory polyradiculoneuropathy complicated by factor VIII antibody.
Neurology
|September 1, 1983
Summary
A patient with chronic inflammatory polyradiculoneuropathy developed a rare bleeding disorder due to an antibody to factor VIII. Researchers also found antibodies targeting peripheral nerve myelin, suggesting immune system dysregulation.
Area of Science:
- Neurology
- Immunology
- Hematology
Background:
- Chronic inflammatory polyradiculoneuropathy (CIPD) is an autoimmune disorder affecting peripheral nerves.
- Coagulopathy, or bleeding disorders, can arise from various causes, including autoimmune conditions.
- Antibodies play a crucial role in immune responses and can sometimes target self-antigens.
Observation:
- A 66-year-old male patient with a history of chronic inflammatory polyradiculoneuropathy presented with a coagulopathy.
- The coagulopathy was identified as being caused by the development of an antibody to factor VIII.
- Concurrently, a high titer of antibody to peripheral nerve myelin was detected in the patient.
Findings:
- Both the antibody to factor VIII and the antibody to peripheral nerve myelin were of the immunoglobulin G (IgG) class.
- Immunological assays confirmed that these two antibodies were distinct, indicating separate autoimmune targets.
- This represents a previously unreported association between factor VIII antibodies and peripheral nerve myelin antibodies in the context of CIPD.
Implications:
- The co-occurrence of these distinct antibodies suggests a potential underlying disturbance in immunoregulation in patients with chronic inflammatory polyradiculoneuropathy.
- This finding may open new avenues for understanding the complex pathophysiology of CIPD.
- Further research into immune dysregulation in CIPD could lead to novel diagnostic markers or therapeutic strategies.